Full-Time

Senior Machine Learning Engineer

Posted on 10/18/2023

Absci

Absci

51-200 employees

Biotech company specializing in protein production

Biotechnology
Healthcare

Senior

Remote in USA + 1 more

More locations: Vancouver, WA, USA

The position is remote within the United States, Canada, Serbia, or Switzerland, with hybrid work available in Vancouver, WA;, New York City; or Belgrade Serbia. Absci is a global company with headquarters in the Pacific Northwest US and an AI Research Lab in New York City.

Category
Applied Machine Learning
Deep Learning
Natural Language Processing (NLP)
AI & Machine Learning
Required Skills
Python
Requirements
  • 4-8+ years of experience designing and building production grade software solutions
  • 4+ years of experience working on ML/AI Systems
  • Proven Track record of creating an engineering project roadmaps and executing on it by delivering high impact work
  • Proven track record of fostering high performing teams and upleveling those around you by coaching and mentoring less experienced engineers on the team
  • Experience building ML/AI systems within the Python ecosystem in the cloud, on-premises, or hybrid
  • Excellent written and oral communication skills
  • Comfortable working in a fast-paced work environment with high autonomy and matching accountability
Responsibilities
  • Act as the technical lead and owner for specific problem spaces in AI workflows
  • Building ML/AI software systems using various tools
  • Work with interdisciplinary teams to build consensus and define achievable product roadmaps
  • Set and implement strategy to deliver on team's objectives and manage technical debt
  • Mentor and coach less experienced engineers on the team

AbSci improves protein expression and biomanufacturing in the biotech industry with its advanced platform that uses a semi-oxidizing cytoplasm and a dual inducible promoter system for precise control over protein production. Its standout product, SoluPure, simplifies protein purification without chromatography, making the process faster and more cost-effective. AbSci sets itself apart by offering proprietary technologies that enhance drug discovery and manufacturing, aiming to replace traditional methods with more efficient solutions. The company's goal is to challenge established practices and create tools that improve the production of life-changing biologics.

Company Stage

IPO

Total Funding

$221.7M

Headquarters

Vancouver, Washington

Founded

2011

Growth & Insights
Headcount

6 month growth

3%

1 year growth

0%

2 year growth

-8%
Simplify Jobs

Simplify's Take

What believers are saying

  • Absci's AI platform enables breakthroughs in de novo antibody design, like ABS-201.
  • Strategic collaborations with AstraZeneca and MSK enhance Absci's drug development capabilities.
  • Recent $86.4M public stock offering strengthens Absci's financial position for R&D.

What critics are saying

  • Increased competition from AI-driven drug discovery companies like Insilico Medicine.
  • Challenges in scaling production due to the 'scale-cost paradox' in biomanufacturing.
  • Dependence on strategic partnerships, which may not yield expected results.

What makes Absci unique

  • Absci uses AI and synthetic biology for novel protein-based drug discovery.
  • Their SoluPure method simplifies protein purification, reducing costs and improving efficiency.
  • Absci's high-throughput platform generates active protein products in just three months.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE